Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal – CNBC

by

  1. Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal  CNBC
  2. Merck posts narrower-than-expected loss as sales of top drugs beat Street estimates  Yahoo News
  3. Merck Posts Narrower Q2 Loss, Lifts Sales Forecast On Keytruda Boost  TheStreet
  4. Merck Stock: Sales Outplays Covid Decline, But Comes In With Per-Share Losses  Investor’s Business Daily
  5. Merck Non-GAAP EPS of -$2.06, revenue of $15B beats by $560M (NYSE:MRK)  Seeking Alpha
  6. View Full Coverage on Google News

Leave a Comment